Antibiotic prescription following ventilation in children with RSV-LRTI was associated with a 1.21-day shorter duration of ventilation and a 2.07-day shorter length of hospital stay.
Hospital-onset sepsis is twice as deadly as community-onset sepsis and increases the risk of death 3-fold, according to the results of a cohort study comprising 2.3 million adult patients.
The FDA has accepted New Drug Applications for oral and IV formulations of Nabriva Therapeutics’ lefamulin for the treatment of community-acquired bacterial pneumonia.
